Ketamine and Kidney Injury in Cardiac Surgery

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

March 2, 2022

Primary Completion Date

September 5, 2025

Study Completion Date

June 30, 2026

Conditions
Cardiac Surgery
Interventions
DRUG

Ketamine

1-2 mg/kg induction with additional medication administered as needed to achieve intubating conditions

DRUG

Propofol

0.5-1 mg/kg induction with additional medication administered as needed to achieve intubating conditions

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05268562 - Ketamine and Kidney Injury in Cardiac Surgery | Biotech Hunter | Biotech Hunter